EICHORCondition: Psoriatic Arthritis (PsA) · Sponsor: AbbVie
The purpose of this study is to evaluate the safety and efficacy of risankizumab in adults with moderately to severely active psoriatic arthritis (PsA).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Pinnacle Research Group /ID# 167953 | Anniston, Alabama, United States | — |
| St. Jude Heritage /ID# 166842 | Fullerton, California, United States | — |
| Newport Huntington Medica /ID# 207423 | Huntington Beach, California, United States | — |
| Arthritis & Osteo Medical Ctr /ID# 166541 | La Palma, California, United States | — |
| East Bay Rheumatology Medical /ID# 166845 | San Leandro, California, United States | — |
| Inland Rheum Clin Trials Inc. /ID# 166621 | Upland, California, United States | — |
| Denver Arthritis Clinic /ID# 166442 | Denver, Colorado, United States | — |
| New England Research Associates, LLC /ID# 166525 | Bridgeport, Connecticut, United States | — |
| Yale University /ID# 166330 | New Haven, Connecticut, United States | — |
| Arthritis & Rheumatic Disease Specialties /ID# 212582 | Aventura, Florida, United States | — |
| SIMED Health, LLC /ID# 207457 | Gainesville, Florida, United States | — |
| Sweet Hope Research Specialty Inc /ID# 168163 | Hialeah, Florida, United States | — |
+ 126 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03671148